Literature DB >> 7529877

Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies.

D Eilat1, W F Anderson.   

Abstract

Nucleic acid binding autoantibodies are the hallmark of the human autoimmune disease, systemic lupus erythematosus (SLE) and are also prevalent in mouse models of this disease. The immunologic stimuli for the production of these antibodies as well as their pathogenic mechanisms are not well understood. However, extensive immunochemical and genetic studies, together with initial crystallographic analysis and computer modeling, have suggested several structure-function correlates which will form the basis for future research. The anti-DNA and anti-RNA autoantibodies comprise a continuous spectrum of specificities in which a delicate balance exists between the binding to the sugar-phosphate backbone and the interactions with the heterocyclic bases of the nucleic acid. Prominent in these interactions are the products of specific V-region immunoglobulin genes, some of which appear to be uniquely suitable for nucleic acid binding. Other structural elements encoded by D minigenes, N sequences and somatic mutations, help to increase the affinity of the binding interaction, and may also increase the repertoire of nucleic acid binding antibodies by combining with a relatively large number of additional V-gene products. Initial crystallographic analyses of anti-DNA antibodies indicate some fundamental differences in the structure and shape of ssDNA and dsDNA antibody combining sites. However, they also suggest a considerable degree of flexibility of both antibody and antigen, which is induced by their binding interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529877     DOI: 10.1016/0161-5890(94)90154-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

Review 1.  The antigenic properties of bacterial DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

2.  B cell tolerance and positive selection in lupus.

Authors:  Dan Eilat; Matthias Wabl
Journal:  J Immunol       Date:  2012-07-15       Impact factor: 5.422

3.  Impact of DNA hairpin folding energetics on antibody-ssDNA association.

Authors:  Zhonghui Ou; Christopher A Bottoms; Michael T Henzl; John J Tanner
Journal:  J Mol Biol       Date:  2007-10-03       Impact factor: 5.469

4.  Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen.

Authors:  Boris Alabyev; Raja Vuyyuru; Tim Manser
Journal:  Int Immunol       Date:  2008-08-08       Impact factor: 4.823

5.  Structural models of antibody variable fragments: a method for investigating binding mechanisms.

Authors:  S Petit; F Brard; G Coquerel; G Perez; F Tron
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

6.  Thermodynamic analysis of monoclonal antibody binding to duplex DNA.

Authors:  J Tanha; J S Lee
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

7.  Specificity and binding kinetics of murine lupus anti-DNA monoclonal antibodies implicate different stimuli for their production.

Authors:  E R Eivazova; J M McDonnell; B J Sutton; N A Staines
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

8.  The influence of DNA size on the binding of antibodies to DNA in the sera of normal human subjects and patients with systemic lupus erythematosus (SLE).

Authors:  D S Pisetsky; T C Gonzalez
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

9.  Conformational Abs recognizing a generic amyloid fibril epitope.

Authors:  Brian O'Nuallain; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

10.  Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire.

Authors:  Sooghee Chang; Liu Yang; Young Mee Moon; Young Gyu Cho; So Youn Min; Tae Joo Kim; Young Joo Kim; Wilson Patrick; Ho-Youn Kim; Chandra Mohan
Journal:  Mol Immunol       Date:  2009-08-21       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.